DaVita, the dialysis unit of kidney care service provider,
DaVita HealthCare Partners Inc.
) entered into a strategic alliance with Cureatr with the aim to
improve nationwide communication and care coordination among care
teams at dialysis centers. Cureatr offers mobile care
coordination solution for healthcare providers.
DaVita provides an extensive range of healthcare services to
patients throughout the United States and abroad. However, it
encounters serious care coordination challenges. Thus, in order
to optimize care coordination and generate reports on key quality
measures for improvement, it requires adequate technological
support. Cureatr's enterprise messaging and workflow navigation
solutions will ensure better clinical information sharing for
DaVita has already implemented Cureatr solutions in its
operations in Atlanta and is upbeat on the prospects as it has
received a favorable response. Additionally, the company aims to
expand its scale of operations and eventually utilize Cureatr
solutions in other locations.
This partnership will allow DaVita to offer the iPhone and web
apps of Cureatr to its facility administrators, care managers,
nurses and affiliated nephrologists. To improve communication
within the dialysis care teams of DaVita, the provision will
include Health Insurance Portability and Accountability Act
(HIPAA)-secure group messaging system with read receipts, secure
photo sharing technology, and seamless integration with the
existing scheduling and directory systems. This facilitates
doctors, nurses and other care-team members to provide high
quality care to their patients.
We believe that this partnership will auger well for DaVita as
Cureatr's proficiency will aid the company to overcome
communication barriers and deliver more efficient patient care as
well as induce growth.
Among its recent ventures, last week, DaVita and Myriad RBM
entered into a strategic liaison to perform a protein biomarker
discovery research. Myriad RBM is a wholly owned subsidiary of a
leading molecular diagnostic company,
Myriad Genetics Inc.
). The objective is to develop and introduce diagnostic tests
into the market for the better treatment of dialysis
DaVita currently carries a Zacks Rank #3 (Hold). Among others
in the industry,
China Cord Blood Corporation
) carries a Zacks Rank #2 (Buy) while
Adus HomeCare Corporation
) carries a favorable Zacks Rank #1 (Strong Buy).
ADDUS HOMECARE (ADUS): Free Stock Analysis
CHINA CORD BLD (CO): Free Stock Analysis
DAVITA INC (DVA): Free Stock Analysis Report
MYRIAD GENETICS (MYGN): Free Stock Analysis
To read this article on Zacks.com click here.